These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1359693

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis.
    Lepper AW, Elleman TC, Hoyne PA, Lehrbach PR, Atwell JL, Schwartzkoff CL, Egerton JR, Tennent JM.
    Vet Microbiol; 1993 Jul; 36(1-2):175-83. PubMed ID: 7901935
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA, Gohary KG, Ball LM, Hess JF.
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Estimation of fimbrial vaccine effectiveness in protection against keratoconjunctivitis infectiosa in calves considering different routes of introducing vaccine antigene.
    Misiura M.
    Arch Vet Pol; 1994 Oct; 34(3-4):177-86. PubMed ID: 8891172
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C, Jayappa HG, Goodnow RA.
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [Abstract] [Full Text] [Related]

  • 16. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA, Hess JF, George LW.
    Vaccine; 2004 Dec 09; 23(4):537-45. PubMed ID: 15530703
    [Abstract] [Full Text] [Related]

  • 17. Whole-bacterial cell enzyme-linked immunosorbent assay for cell-bound Moraxella bovis pili.
    Prieto CI, Rodriguez ME, Bosch A, Chirdo FG, Yantorno OM.
    Vet Microbiol; 2003 Feb 02; 91(2-3):157-68. PubMed ID: 12458165
    [Abstract] [Full Text] [Related]

  • 18. Vaccine against infectious bovine keratoconjunctivitis: a new approach to optimize the production of highly piliated Moraxella bovis cells.
    Prieto CI, Bosch A, Zielinski G, Cúneo J, Yantorno OM.
    Vaccine; 2008 Dec 02; 26(51):6542-9. PubMed ID: 18852003
    [Abstract] [Full Text] [Related]

  • 19. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG, Lehr C.
    Am J Vet Res; 1986 Oct 02; 47(10):2217-21. PubMed ID: 2877604
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.